| Application no. and date | 12701742.4 (espacenet) (Federated) (European Patent Register), 20120127 | | Patent/reg. no. and date | DK/EP 2668212, 20180321 | | Publication date | 20131204 | | Priority no. and date | EP 11305088, 20110128, EP 11305089, 20110128, EP 11305513, 20110429, EP 11305514, 20110429, EP 11306039, 20110812, EP 11306040, 20110812, EP 11306201, 20110922, EP 11306202, 20110922, EP 11306449, 20111108, EP 11306450, 20111108 | | EP pub. no. and date |
EP 2668212 20131204 | | Effective date | | | Applicant/owner | Saonofi Biotechnology, 54 rue La Boetie
75008 Paris, FR | | Applicant ref. no. | SAN DE2011/013EP | | Inventor | HANOTIN, Corinne, c/o SANOFI
Diabetes - R&D/Development
54 rue La Boétie
F-75008 Paris, FR,
BESSAC, Laurence, c/o SANOFI
Diabetes - R&D/Development
54 rue La Boétie
F-75008 Paris, FR,
CHAUDHARI, Umesh, c/o SANOFI US
R&D Bridgewater
Phase III - Clinical Development
Mail Stop: 55B-415B
55 Corporate Drive
Bridgewater, NJ 08807, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61J 1/05 (2006.01) , A61K 31/215 (2006.01) , A61K 31/366 (2006.01) , A61K 31/395 (2006.01) , A61K 31/404 (2006.01) , A61K 31/435 (2006.01) , A61K 31/47 (2006.01) , A61K 31/505 (2006.01) , A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61K 45/06 (2006.01) , C07K 14/47 (2006.01) , C07K 16/40 (2006.01) | | Title | HUMANE ANTISTOFFER MOD PCSK9 TIL ANVENDELSE I FREMGANGSMÅDER TIL BEHANDLING AF BESTEMTE GRUPPER AF PERSONER | | Int. application no. | EP2012051320 | | Int. publication no. | WO2012101252 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
